We have collected information about Prevention Of Recurrent Preterm Delivery By 17 Alpha-Hydroxyprogesterone Caproate for you. Follow the links to find out details on Prevention Of Recurrent Preterm Delivery By 17 Alpha-Hydroxyprogesterone Caproate.
https://www.nejm.org/doi/full/10.1056/NEJMoa035140
Original Article from The New England Journal of Medicine — Prevention of Recurrent Preterm Delivery by 17 Alpha-Hydroxyprogesterone CaproateAuthor: Paul J. Meis, Mark Klebanoff, Elizabeth Thom, Mitchell P. Dombrowski, Baha Sibai, Atef H. Moawad, Ca...
https://www.ncbi.nlm.nih.gov/pubmed/12802023
Jun 12, 2003 · The results of several small trials have suggested that 17 alpha-hydroxyprogesterone caproate (17P) may reduce the risk of preterm delivery. METHODS: We conducted a double-blind, placebo-controlled trial involving pregnant women with a documented history of …Author: Paul J. Meis, Mark Klebanoff, Elizabeth Thom, Mitchell P. Dombrowski, Baha Sibai, Atef H. Moawad, Ca...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855838/
In one trial and one systematic review and meta-analysis , 17 alpha-hydroxyprogesterone caproate (17P) has been associated with a reduction of recurrent SPTB. It is unclear if the effects of 17P (for prior SPTB) and cerclage (for short CL) are additive in women with both risk factors.Author: Vincenzo Berghella, Dana Figueroa, Jeff M. Szychowski, John Owen, Gary D.V. Hankins, Jay D. Iams, Je...
https://www.smfm.org/publications/280-smfm-statement-use-of-17-alpha-hydroxyprogesterone-caproate-for-prevention-of-recurrent-preterm-birth
SMFM Statement: Use of 17-alpha hydroxyprogesterone caproate for prevention of recurrent preterm birth
https://www.researchgate.net/publication/10712383_Prevention_of_Recurrent_Preterm_Delivery_by_17_Alpha-Hydroxyprogesterone_Caproate
Prevention of Recurrent Preterm Delivery by 17 Alpha-Hydroxyprogesterone Caproate Article (PDF Available) in New England Journal of Medicine 348(24):2379-85 · July 2003 with 256 Reads
https://www.sciencedirect.com/science/article/pii/S0002937807008800
Prophylaxis with 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery: does gestational age at initiation of treatment matter? Presented at the 27th Annual Clinical Meeting of the Society for Maternal–Fetal Medicine, San Francisco, CA, Feb. 5-10, 2007. ...Author: Helen Y. How, John R. Barton, Niki B. Istwan, Debbie J. Rhea, Gary J. Stanziano
Searching for Prevention Of Recurrent Preterm Delivery By 17 Alpha-Hydroxyprogesterone Caproate?
You can just click the links above. The data is collected for you.
